SECRETION OF IL-1BETA FROM TKI-RESISTANT CELLS CONTRIBUTES TO BCR-ABL MUTATION-INDEPENDENT TKI RESISTANCE IN CHRONIC MYELOID LEUKEMIA

Park S. -G.; Lee C. -R.; Kang J. -A.

首页> 外文期刊>Cytokine >SECRETION OF IL-1BETA FROM TKI-RESISTANT CELLS CONTRIBUTES TO BCR-ABL MUTATION-INDEPENDENT TKI RESISTANCE IN CHRONIC MYELOID LEUKEMIA

【24h】

SECRETION OF IL-1BETA FROM TKI-RESISTANT CELLS CONTRIBUTES TO BCR-ABL MUTATION-INDEPENDENT TKI RESISTANCE IN CHRONIC MYELOID LEUKEMIA

机译：慢性髓性白血病中TKI抵抗细胞中IL-1BET的分泌有助于BCR-ABL突变无关的TKI抵抗

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Cytokine》 |2016年第null期|共1页
作者
Park S. -G.; Lee C. -R.; Kang J. -A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类细胞生物学;
关键词

相似文献

外文文献
中文文献
专利

1. SECRETION OF IL-1BETA FROM TKI-RESISTANT CELLS CONTRIBUTES TO BCR-ABL MUTATION-INDEPENDENT TKI RESISTANCE IN CHRONIC MYELOID LEUKEMIA [J] . Park S. -G., Lee C. -R., Kang J. -A. Cytokine . 2016,第Null期

机译：慢性髓性白血病中TKI抵抗细胞中IL-1BET的分泌有助于BCR-ABL突变无关的TKI抵抗
2. SECRETION OF IL-1BETA FROM TKI-RESISTANT CELLS CONTRIBUTES TO BCR-ABL MUTATION-INDEPENDENT TKI RESISTANCE IN CHRONIC MYELOID LEUKEMIA [J] . Park S. -G., Lee C. -R., Kang J. -A. Cytokine . 2016,第Null期

机译：来自TKI抗性细胞的IL-1Beta的分泌有助于慢性骨髓白血病中的BCR-ABL突变无关的TKI抗性
3. Secretion of IL-1 beta from imatinib-resistant chronic myeloid leukemia cells contributes to BCR-ABL mutation-independent imatinib resistance [J] . Lee Cho-Rong, Kang Jung-Ah, Kim Hye-Eun, FEBS letters. . 2016,第3期

机译：伊马替尼耐药的慢性粒细胞白血病细胞分泌IL-1β有助于非BCR-ABL突变的伊马替尼耐药
4. Absolute quantification for clinical-resistant BCR-ABL mutants from Chronic myeloid leukemia (CML) [C] . Jung Ok Park, Gum Yong Kang, Sun Kyu Choi, ASMS Conference on Mass Spectrometry and Allied Topics . 2008

机译：慢性骨髓白血病（CML）的临床抗性BCR-ABL突变体的绝对量化
5. Suppression of BCR-ABL by siRNA-loaded nanoparticles for the treatment of Chronic Myeloid Leukemia [D] . Gavrilov, Kseniya Eugene. 2015

机译：载有siRNA的纳米颗粒抑制BCR-ABL用于治疗慢性粒细胞白血病
6. Sensitive Detection of Pre-Existing BCR-ABL Kinase Domain Mutations in CD34+ Cells of Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients Is Associated with Imatinib Resistance: Implications in the Post-Imatinib Era [O] . Zafar Iqbal, Aamer Aleem, Mudassar Iqbal, 2010

机译：新诊断的慢性阶段性骨髓性白血病患者CD34 +细胞中先前存在的BCR-ABL激酶结构域突变的敏感检测与伊马替尼耐药相关：在伊马替尼时代后的意义
7. Sensitive detection of pre-existing BCR-ABL kinase domain mutations in CD34+ cells of newly diagnosed chronic-phase chronic myeloid leukemia patients is associated with imatinib resistance: implications in the post-imatinib era. [O] . Zafar Iqbal, Aamer Aleem, Mudassar Iqbal, 2013

机译：敏感检测新诊断的慢性粒细胞白血病患者CD34 +细胞中已存在的BCR-aBL激酶结构域突变与伊马替尼耐药相关：伊马替尼后时代的影响。

SECRETION OF IL-1BETA FROM TKI-RESISTANT CELLS CONTRIBUTES TO BCR-ABL MUTATION-INDEPENDENT TKI RESISTANCE IN CHRONIC MYELOID LEUKEMIA

著录项

相似文献

相关主题

期刊订阅